- Home
- CRVS vs PFIS Comparison
CRVS vs PFIS Comparison
Compare CRVS & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- PFIS
- Stock Information
- Founded
- CRVS 2014
- PFIS 1905
- Country
- CRVS United States
- PFIS United States
- Employees
- CRVS N/A
- PFIS N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- PFIS Major Banks
- Sector
- CRVS Health Care
- PFIS Finance
- Exchange
- CRVS Nasdaq
- PFIS Nasdaq
- Market Cap
- CRVS 459.0M
- PFIS 523.7M
- IPO Year
- CRVS 2016
- PFIS N/A
- Fundamental
- Price
- CRVS $5.83
- PFIS $52.51
- Analyst Decision
- CRVS Strong Buy
- PFIS
- Analyst Count
- CRVS 4
- PFIS 0
- Target Price
- CRVS $15.00
- PFIS N/A
- AVG Volume (30 Days)
- CRVS 596.4K
- PFIS 35.2K
- Earning Date
- CRVS 11-11-2025
- PFIS 11-04-2025
- Dividend Yield
- CRVS N/A
- PFIS 4.68%
- EPS Growth
- CRVS N/A
- PFIS 39.41
- EPS
- CRVS N/A
- PFIS 3.35
- Revenue
- CRVS N/A
- PFIS $165,604,000.00
- Revenue This Year
- CRVS N/A
- PFIS $70.81
- Revenue Next Year
- CRVS N/A
- PFIS $4.92
- P/E Ratio
- CRVS N/A
- PFIS $15.72
- Revenue Growth
- CRVS N/A
- PFIS 82.33
- 52 Week Low
- CRVS $2.54
- PFIS $38.90
- 52 Week High
- CRVS $10.00
- PFIS $59.70
- Technical
- Relative Strength Index (RSI)
- CRVS 58.56
- PFIS 54.06
- Support Level
- CRVS $5.90
- PFIS $52.08
- Resistance Level
- CRVS $6.30
- PFIS $53.98
- Average True Range (ATR)
- CRVS 0.32
- PFIS 1.05
- MACD
- CRVS -0.00
- PFIS -0.05
- Stochastic Oscillator
- CRVS 53.92
- PFIS 34.96
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.